Full Year 2026 WISR Ltd Earnings Call Transcript

Aug 27, 2025 / 12:00AM GMT

Key Points

Positve
  • Wisr Ltd (ASX:WZR) achieved 101% loan origination growth in FY25, significantly exceeding their initial guidance.
  • The company delivered EBITDA profitability for the year, marking a multi-million dollar turnaround.
  • Wisr Ltd's portfolio yield increased to 11.2%, with a 30 basis point uplift from the prior year.
  • The company successfully closed a $267 million warehouse deal with Barclays, reducing overall funding costs.
  • Wisr Ltd's automation efforts have led to 80% of loans being automatically approved, enhancing operational efficiency.
Negative
  • Revenue for the year was broadly flat compared to FY24, despite strong origination growth.
  • There is a natural lag between loan originations and revenue recognition, affecting immediate revenue growth.
  • Operating expenses increased by 7% to $28.4 million, which needs to be considered in the context of origination growth.
  • The company is still not back to its previous peak in terms of market presence, despite recent growth.
  • Wisr Ltd's market share in personal lending remains small, indicating room for improvement in capturing market opportunities.
Operator

We have CEO, Andrew Goodwin; and CFO, Matthew Lewis, who will take us through the presentation that was lodged with the ASX this morning.

As always, before we kick off, just a little bit of housekeeping, we invite research analysts to ask questions at the end of the presentation. To do so, please type them into the online Q&A function and we will get to them at the end of the meeting. As always, this webinar is also being recorded, and we will post the recording onto the WISR website later today.

And with that, I will now hand it over to Andrew.

Andrew Goodwin
WISR Ltd - Chief Executive Officer

Thanks, Eleanor, and good morning, everyone. Thanks for joining us. So just to kick off, we live in an evolving world. And as part of this our vision has also evolved as part of our annual strategic review process, and this is all about meeting the evolving needs of our customers.

As many of you may know, DNA is all around financial wellness, that has really been the core purpose of the business from day one. This has evolved to a world

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot